NCT02065869 2023-09-29Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell TransplantBellicum PharmaceuticalsPhase 1/2 Terminated187 enrolled 8 charts
NCT03733249 2023-09-26Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyBellicum PharmaceuticalsPhase 1/2 Terminated187 enrolled 8 charts
NCT00771810 2017-11-13Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal CancerTarix PharmaceuticalsPhase 2 Completed34 enrolled 19 charts